ClinicalTrials.Veeva

Menu

Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording (RCFLoS)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Maternal Heart Rate

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Signal loss in cardiotocography (CTG) recordings is numerous and frequent, whether due to artifacts in signal acquisition or confusion over inadvertent maternal heart rate recording, with various negative consequences for neonatal morbidity and unnecessary obstetric interventions. Data on this issue are 10 to 15 years old. CTG remains the primary method for assessing fetal well-being during labor, almost systematically.

Enrollment

500 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult female (≥ 18 years old)
  • Patient treated at a hospital between February 1, 2024 and February 28, 2024
  • Having undergone cardiotocography in the labor and delivery room
  • Gestational age at delivery >36 weeks

Exclusion criteria

  • Patient who has expressed opposition to the use of medical record data
  • Patient without CTG
  • Gestational age at delivery <36 weeks

Trial contacts and locations

1

Loading...

Central trial contact

Georges-Emmanuel ROTH, Midwife

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems